期刊的影响因子--文章列表

期刊文章列表
Yu Tengjie，Zhou Zhihao，Liu Shijia，Li Changjian，Zhang Zhiwei，Zhang Yong，Jin Wei，Liu Keanqi，Mao Shuying，Zhu Lei，Xie Lin，Wang Guangji，Liang Yan.The role of phosphatidylcholine 34:1 in the occurrence, development and treatment of ulcerative colitis[J].药学学报,2023,第3期 Wu Jiang，Gou Wenfeng，Wang Zhiyun，Chang Huajie，Li Deguan，Hou Wenbin，Liu Changxiao.Discovery of the radio-protecting effect of Ecliptae Herba, its constituents and targeting p53-mediated apoptosis in vitro and in vivo[J].药学学报,2023,第3期 Bi Qunjie，Song Xu，Zhao Yangyang，Hu Xueyi，Yang Huan，Jin Rongrong，Nie Yu.Mucus-penetrating nonviral gene vaccine processed in the epithelium for inducing advanced vaginal mucosal immune responses[J].药学学报,2023,第3期 Zhang Lei，Ye Biwei，Chen Zhuo，Chen Zhesheng.Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers[J].药学学报,2023,第3期 Zhang Lu，Zhou Xiaolei，Liu Bowen，Shi Xuhe，Li Xianmeng，Xu Feifei，Fu Xueli，Wang Xue，Ye Kai，Jin Tianzhi，Sun Huimin，Li Qianqian，Zhang Weiying，Ye Lihong.HBXIP blocks myosin-IIA assembly by phosphorylating and interacting with NMHC-IIA in breast cancer metastasis[J].药学学报,2023,第3期 Zhang Tianguang，Miao Chaoyu.Mitochondrial transplantation as a promising therapy for mitochondrial diseases[J].药学学报,2023,第3期 Feng Juanjuan，Lian Zhengke，Xia Xinting，Lu Yue，Hu Kewen，Zhang Yunpeng，Liu Yanan，Hu Longmiao，Yuan Kun，Sun Zhenliang，Pang Xiufeng.Targeting metabolic vulnerability in mitochondria conquers MEK inhibitor resistance in KRAS-mutant lung cancer[J].药学学报,2023,第3期 Wu Lingling，Zhao Qinxin，Wang Qinghua，Zhang Qingyang，Yang Feiya，Zheng Bo，Hu Haiyu，Xing Nianzeng.Membrane dual-targeting probes:A promising strategy for fluorescence-guided prostate cancer surgery and lymph node metastases detection[J].药学学报,2023,第3期 Chen Zhe，Meng Chaoyang，Mai Junhua，Liu Yongbin，Li Hangwen，Shen Haifa.An mRNA vaccine elicits STING-dependent antitumor immune responses[J].药学学报,2023,第3期谢明卉，汪昭，孙彦莹，姜向毅，展鹏，刘新泳，康东伟（山东大学药学院药物化学研究所化学生物学教育部重点实验室）.HIV-1包膜糖蛋白gp120小分子抑制剂的研究进展[J].药学学报,2023,第3期 Duan Xing，Zhang Yi，Guo Mengran，Fan Na，Chen Kepan，Qin Shugang，Xiao Wen，Zheng Qian，Huang Hai，Wei Xiawei，Wei Yuquan，Song Xiangrong.Sodium alginate coating simultaneously increases the biosafety and immunotherapeutic activity of the cationic mRNA nanovaccine[J].药学学报,2023,第3期 Jin Xin，Wang Shuai，Zhao Limin，Huang Wenjuan，Zhang Yinxiang，Pannecouque Christophe，De Clercq Erik，Meng Ge，Piao Huri，Chen Fener.Development of fluorine-substituted NH_2- biphenyl-diarylpyrimidines as highly potent non-nucleoside reverse transcriptase inhibitors:Boosting the safety and metabolic stability[J].药学学报,2023,第3期 Zhou Zheng，Li Keying，Chu Yongchao，Li Chao，Zhang Tongyu，Liu Peixin，Sun Tao，Jiang Chen.ROS-removing nano-medicine for navigating inflammatory microenvironment to enhance anti-epileptic therapy[J].药学学报,2023,第3期 Huang Xueqin，Sheng Bingbing，Tian Hemi，Chen Qiuxia，Yang Yingqi，Bui Brian，Pi Jiang，Cai Huaihong，Chen Shanze，Zhang Jianglin，Chen Wei，Zhou Haibo，Sun Pinghua.Real-time SERS monitoring anticancer drug release along with SERS/MR imaging for pHsensitive chemo-phototherapy[J].药学学报,2023,第3期李承哲^1,2，彭成¹，李小翠^1,2，刘娟^1,2，周勤梅^1,2,3，蒙春旺^1,2，刘菲^1,2，熊亮^1,2（成都中医药大学药学院西南特色中药资源国家重点实验室；成都中医药大学西南特色药材创新药物成分研究所；成都中医药大学中医药创新研究院）.蓬莪术中一个新的榄香烷型倍半萜苷[J].药学学报,2023,第3期 Zhou Qian，Le Meiling，Yang Yiyi，Wang Wenjuan，Huang Yuqi，Wang Quan，Tian Yijing，Jiang Meiyan，Rao Yong，Luo Haibin，Wu Yinuo.Discovery of novel phosphodiesterase-1 inhibitors for curing vascular dementia:Suppression of neuroinflammation by blocking NF-kappaB transcription regulation and activating cAMP/CREB axis[J].药学学报,2023,第3期 Zhao Mengnan，Wang Rujing，Yang Kunmeng，Jiang Yuhong，Peng Yachen，Li Yuke，Zhang Zhen，Ding Jianxun，Shi Sanjun.Nucleic acid nanoassembly-enhanced RNA therapeutics and diagnosis[J].药学学报,2023,第3期 Xu Minxuan，Tan Jun，Zhu Liancai，Ge Chenxu，Dong Wei，Dai Xianling，Kuang Qin，Zhong Shaoyu，Lai Lili，Yi Chao，Li Qiang，Lou Deshuai，Hu Linfeng，Liu Xi，Kuang Gang，Luo Jing，Feng Jing，Wang Bochu.The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway[J].药学学报,2023,第3期 Yoon Sae Bom，Hong Hyowon，Lim Hee Jong，Choi Ji Hye，Choi Yoon Pyo，Seo Seong Wook，Lee Hyuk Woo，Chae Chong Hak，Park Woo Kyu，Kim Hyun Young，Jeong Daeyoung，De Tran Quang，Myung Chang Seon，Cho Heeyeong.A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-kappaB pathway[J].药学学报,2023,第3期 Chen Keliang，Wang Tao，Li Yong，Wu Jun，Zhao Chengxiao，Liu Sheng，Sun Fengrun，Fang Yehong，Hu Jiahuan，Hu Jinping，Zhang Chongjing，Yu Haibo，Ma Chao，Yu Shishan.Rhodojaponin VI indirectly targets Cav2.2 channels via N-ethylmaleimide-sensitive fusion protein to alleviate neuropathic pain[J].药学学报,2023,第3期 Wei Xiaoli，Yin Fan，Wu Miaomiao，Xie Qianqian，Zhao Xueqin，Zhu Cheng，Xie Ruiqian，Chen Chongqing，Liu Menghua，Wang Xueying，Ren Ruixue，Kang Guijie，Zhu Chenwen，Cong Jingjing，Wang Hua，Wang Xuefu.G protein-coupled receptor 35 attenuates nonalcoholic steatohepatitis by reprogramming cholesterol homeostasis in hepatocytes[J].药学学报,2023,第3期 Dong Zhihui，Huang Zhuoshan，Li Senlin，Wang Ying，Yao Yandan，Yang Xianzhu，Xu Xiaoding.Nanoparticles (NPs)-mediated systemic mRNA delivery to reverse trastuzumab resistance for effective breast cancer therapy[J].药学学报,2023,第3期 Feng Zhuo，Wang Yuchen，Xu Haiheng，Guo Yunfei，Xia Wen，Zhao Chenxuan，Zhao Xiaozhi，Wu Jinhui.Recent advances in bacterial therapeutics based on sense and response[J].药学学报,2023,第3期 Shao Ning，Ma Xueyang，Zhang Yingying，Yang Donghui，Ma Ming，Tang Gongli.Dihydrofolate reductase-like protein inactivates hemiaminal pharmacophore for self-resistance in safracin biosynthesis[J].药学学报,2023,第3期郭宗儒（中国医学科学院、北京协和医学院药物研究所）.首创的神经激肽受体拮抗剂阿瑞吡坦[J].药学学报,2023,第3期韦玉芳¹，窦志英¹，金传山²，李蕊汐¹，赵姿雯¹，王丁丁¹，刘玉梅¹，杨卓尔¹，胡容峰²，陈宇洲¹（天津中医药大学中药学院；安徽中医药大学药物制剂技术与应用安徽省重点实验室）.中药汤剂中的微粒研究进展[J].药学学报,2023,第2期李瑞¹，郭修平²，韩燕星²，王璐璐¹，蒋建东^1,2（中国医学科学院北京协和医学院医药生物技术研究所；中国医学科学院北京协和医学院药物研究所天然药物活性物质与功能国家重点实验室）.“标本兼治”的生物学原理[J].药学学报,2023,第2期首页上一页 18 19 20 21 22 下一页尾页共有24页，转到页

期刊文章列表